>Preliminary data in the research of cervical cancer, gastric cancer and other tumors show that Cadonilimab is significantly less toxic than the combination therapy of PD-1 and CTLA-4, and has obvious safety and efficacy advantages.
Janssen/Legendary Bio-CAR-T Therapy Completes Rolling Submission of FDA Biological Products License Application
Time of Update: 2021-05-03
:2em;margin-top:20px;">
Cilta-cel is a CAR-T cell therapy with a differential structure. It contains a 4-1BB costimulatory domain and two antibody domains targeting BCMA. It has the ability to promote the expansion of CD8
Take over charity assistance to Junshi Bio-Treplimumab National Medical Insurance Implementation
Time of Update: 2021-05-03
in China. Therefore, Junshi Bio has fully considered the availability of anti-tumor drugs in China and positioned the market price at similar products. The 1/6 level of overseas pricing is the first to break the monopoly of imported
Microcore Bio-Cidabenamine Lung Cancer Phase 2 Clinical Accepted, Cioroni Approved in China and the U.S.
Time of Update: 2021-05-02
) is a recombinant humanized PD-L1 single domain antibody Fc fusion protein injection that can be injected subcutaneously. It has submitted a new drug application in China and has been included in the priority review. The indication
Bluebird Bio launches Zynteglo in Europe blocked and starts layoffs
Time of Update: 2021-05-02
Due to the frustration of Zynteglo's listing on the first European market, Bluebird Bio is currently laying off employees and plans to "reduce and reshape" its workforce in parts of Germany.
Kangtai Bio-New Coronary Inactivated Vaccine Data: Neutralizing Antibody Is 2.65 Times Recovered
Time of Update: 2021-05-02
7. The clinical data of the new crown vaccine compiled by the medical team of Dongxing Securities shows that the antibody titer vaccine group/recovered multiple of them ranks first in China and fourth in the world.
Tianjing Bio and ABL Bio announced the completion of TJ-L14B Phase 1 clinical trial in the United States...
Time of Update: 2021-05-02
On April 6, Tianjing Biotechnology and ABL Bio of South Korea jointly announced that the first US phase clinical study of the bispecific antibody TJ-L14B/ABL503 jointly developed by the two parties has completed the first patient administration.
Kangfang Bio-IL-4R monoclonal antibody was approved for clinical indication for moderate to severe atopic dermatitis
Time of Update: 2021-05-02
On April 8, the CDE official website showed that Kangfang Biologics Class 1 new drug AK120 injection was approved for clinical use, and the indication is moderate to severe atopic dermatitis.
Yuandong Bio-Caffeine Citrate Injection Consistency Evaluation Supplementary Application Approved
Time of Update: 2021-04-29
On February 25, Chengdu Yuandong Biotech announced that the company's supplementary application for consistency evaluation of caffeine citrate injection was approved by the State Food and Drug
Rongchang Bio-Tetacept was approved, the second new drug for systemic lupus erythematosus in 60 years
Time of Update: 2021-04-28
Overexpression of these factors is an important cause of systemic lupus erythematosus (SLE) and other autoimmune diseases related to B lymphocytes.
2021 AACR | Chinese companies such as BeiGene, Corning Jerry, and Tianjing Bio will make an appearance
Time of Update: 2021-04-28
immune anti-tumor capabilities. According to the press release, the innovative design of KN046 includes the fusion of CTLA-4 and PD-L1 single domain antibodies with different mechanisms, and can target the tumor microenvironment
CanSino Bio-Inhalation Recombinant Novel Coronavirus Vaccine Approved for Clinical Clinic
Time of Update: 2021-04-27
According to relevant media reports, CanSino Bio has previously emphasized that according to the interim data of the global multi-center phase III clinical trial, there has been no serious adverse reaction related to the vaccine.
Tianjing Bio and ABL Bio announce the completion of the first patient administration of TJ-L14B Phase 1 in the United States
Time of Update: 2021-04-24
On April 6, Tianjing Biotechnology and ABL Bio of South Korea jointly announced that the first US phase clinical study of the bispecific antibody TJ-L14B/ABL503 jointly developed by the two parties has completed the first patient administration.
Dr. Guo Bingshi of Tianjing Bio: The world's first Claudin 18.2/4-1BB bispecific antibody has
Time of Update: 2021-04-23
Guo Bingshi, Chief Scientific Officer of Tianjing Biological The collision of tight junction proteins and costimulatory molecules Bispecific antibody therapy is a method of using T cells in the patient's immune system to kill tumors.
This water-based bio-based PUA emulsion can be applied to UV LED curing wood coatings to improve mechanical properties and curing speed
Time of Update: 2021-04-23
family statement, for reference only. If you have any questions, you can leave a message under the official account. >>Background introduction>>
probes in the far red region based on "bio-orthogonal engineering"
Time of Update: 2021-04-23
on live neurons", they comprehensively used bio-orthogonal reactions and membrane protein engineering strategies to develop a series of fluorescent membrane potential probes HVI (hybrid voltage indicator) with high sensitivity and imaging signal-to-noise ratio.
Commun Bio: Deep brain stimulation helps treat diseases
Time of Update: 2021-04-20
html">New discoveries of deep brain simulation put it on par with therapeutics Original source: Musa Ozturk, Ashwin Viswanathan, Sameer A.
Express | Janssen/Legendary Bio-CAR-T Therapy Completes Rolling Submission of FDA Biological Products License Application
Time of Update: 2021-04-19
Janssen/Legendary's cilta-cel is expected to become the second approved cell therapy targeting BCMA this year, bringing more treatment options to patients with multiple myeloma.
[First issue] Tekoro Bio, a leader in the research and development of innovative skin drugs
Time of Update: 2021-04-19
. He completed his master's study and research at Nankai University, then went to the University of Michigan to study for a doctorate in the Department of Organic Chemistry, and then completed postdoctoral research at the University
